Pages that link to "Q104038370"
Jump to navigation
Jump to search
The following pages link to Volker Erfle (Q104038370):
Displaying 31 items.
- Unsung Hero Robert C. Gallo (Q22065525) (← links)
- Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8⁺ T Cell Epitopes (Q28647428) (← links)
- The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT. (Q30484153) (← links)
- Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L. (Q33187731) (← links)
- Modified vaccinia virus Ankara exerts potent immune modulatory activities in a murine model (Q33632203) (← links)
- Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection. (Q34016464) (← links)
- Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. (Q34226966) (← links)
- Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. (Q34467405) (← links)
- Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection (Q34889788) (← links)
- Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: study of immunological memory and long-term toxicology. (Q35995081) (← links)
- Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus. (Q37015233) (← links)
- Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara (Q40506182) (← links)
- Differences between T cell epitopes recognized after immunization and after infection (Q40698979) (← links)
- Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model (Q42829229) (← links)
- Autologous cytotoxicity of natural killer cells derived from HIV-infected patients (Q43912315) (← links)
- Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART. (Q45402397) (← links)
- Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy (Q45406259) (← links)
- Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity (Q45418101) (← links)
- Improved host range selection for recombinant modified vaccinia virus Ankara (Q45724482) (← links)
- Generation of recombinant fowlpox virus using the non-essential F11L orthologue as insertion site and a rapid transient selection strategy (Q45730546) (← links)
- Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques. (Q45733231) (← links)
- A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses (Q46224704) (← links)
- The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use. (Q50582320) (← links)
- Elevated Epstein-Barr virus loads and lower antibody titers in competitive athletes. (Q54057647) (← links)
- Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f (Q57075677) (← links)
- Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals (Q57081485) (← links)
- Evaluation in Rhesus Macaques of Tat and Rev-Targeted Immunization as a Preventive Vaccine against Mucosal Challenge with SHIV-BX08 (Q57081491) (← links)
- Therapeutic vaccination reduces HIV sequence variability (Q57081840) (← links)
- Longitudinal changes in HIV-1-specific T-cell quality associated with viral load dynamic (Q57236200) (← links)
- Vaccines based on Nef and on Nef/DeltaV2 Env (Q81390446) (← links)
- A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus (Q82014730) (← links)